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ACE 2 Enzymes
● ACE 2 Enzymes are significant in this process as they 
activate bradykinin pathways. 
○ COVID enters the cell via the ACE 2 Receptors
○ Pharmacology:
■ The ACE 2 Receptors are blockers
■ Ibuprofen upregulates the ACE 2 Receptors 
● Activation of ACE enzymes cause Bradykinin release.
○ Bradykinins increase cell permeability
○ COVID BAL (broncho-alveolar)  samples show 
upregulation of hyaluronan synthases & downregulation  
of hyaluronidase.
○ Combined with increased lung hyperpermeability 
results in the formation of hyaluronic acid hydrogel 
inhibiting gas exchange ( crazy pavement ground glass 
appearance on CT scan).
JAK 2 Receptors 
● JAK STAT pathway is the path cytokines released  from 
Intracellular to extracellular.
● JAK 2 receptor blockers prevent the release of cytokines.
Bevespi & Alvesco
● Bevespi is a micelle formulation of glycorrpyrolate a long 
known respiratory drying agent. It dries up the secretions 
that Covid lives in.
● Alvesco  has been shown in Korean studies  to be effective 
in treating Covid
● In our study of symptom improvement in 24 Covid positive 
patients Bevespi was effective in reducing symptoms.
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1. Severe acute respiratory syndrome Coronavirus 2 
(SARS-CoV-2) is a single-stranded RNA virus responsible for the 
Coronavirus disease 19 (COVID-19) pandemic. 
2. A hallmark of the virus is its spike protein, which interacts with 
the angiotensin-converting enzyme 2 (ACE-2) receptor to 
invade the cell.  
3. After entry, SARS-Cov-2 hijacks existing cellular machinery to 
self-replicate. The virus binds to the ACE-2 receptors and 
activates bradykinin production. 
4. Repurposed drugs were used to treat COVID-19 early, 
preventing complications of a deadly cytokine storm that 
starts around day 10. 
Goal: Evaluate the overall effectiveness of these repurposed 
drugs: individually and in combination
Introduction
Conclusion
● Early treatment, with a combination of the repurposed 
drugs, interrupts the viral life cycle and prevents the 
progression into a cytokine storm.
● Treatment in the first 10 days for the COVID-19 virus is highly 
effective
● It is unknown as to how effective the current vaccines are 
with the current variants 
Methods
A retrospective 
observational study to 
review the efficacy of 
treatment by measuring 
symptom resolution. 
Quantitative symptomatic 
data was observed for 26 
patients (9 patients were 
55+) with a lab-confirmed, 
positive SARS-CoV-2 test. 
Patients' symptoms 
improved rapidly in the 
first ten days. Symptom 
plot analysis over time with 
correlation coefficient for 
each medicine was 
examined. 
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● Out of 26 patients, eight (30.8%) were treated with lopinavir/ritonavir, 
bamlanvimab, glycopyrrolate-formoterol, ciclesonide, and 
diphenhydramine. Patients experienced a rapid improvement in 
COVID-19 symptoms within 3-5 days. The correlation coefficients for 
each medicine and the number of symptoms was determined. The 
more negative, the faster the resolution of symptoms:
○ Correlation coefficient for Kaletra -0.1407, Bevespi -0.227, Alvesco 
-0.2191, famotidine -0.1554
